Fig 3. Impact choice in frequency cutoff had on number of DRMs resulting in intermediate and/or high-level resistance.

Frequency of the numbers of DRMs, including Intermediate and High-level resistance, that were detected for Protease Inhibitors (PIs) (n = 64), Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (n = 78) and Integrase Strand Transfer Inhibitors (INSTIs) (n = 58) was determined across 5 different % frequency cutoffs including ≥20%, ≥15%, ≥10%, ≥5% and ≥1% using the Stanford HIVdb program from HyDRA Web data.